Cell MedX Corp
OTC:CMXC
Balance Sheet
Balance Sheet Decomposition
Cell MedX Corp
Cell MedX Corp
Balance Sheet
Cell MedX Corp
| May-2015 | May-2016 | May-2017 | May-2018 | May-2019 | May-2020 | May-2021 | May-2022 | May-2023 | May-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+478%
|
0
+9%
|
0
-85%
|
0
+321%
|
0
-16%
|
0
-67%
|
0
-21%
|
0
+150%
|
0
-55%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
1
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+130%
|
1
-13%
|
1
-24%
|
2
+75%
|
2
-14%
|
2
-3%
|
2
+26%
|
2
+21%
|
1
-65%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
3
|
5
|
6
|
7
|
8
|
9
|
9
|
10
|
10
|
|
| Additional Paid In Capital |
0
|
2
|
3
|
5
|
5
|
6
|
7
|
7
|
7
|
9
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
1
-106%
|
1
+17%
|
1
+8%
|
2
-65%
|
2
+14%
|
2
-4%
|
2
-27%
|
2
-19%
|
1
+65%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+478%
|
0
+9%
|
0
-85%
|
0
+321%
|
0
-16%
|
0
-67%
|
0
-21%
|
0
+150%
|
0
-55%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
31
|
31
|
40
|
44
|
44
|
56
|
62
|
63
|
63
|
297
|
|